Why go public now? To enable public participation in an ibogaine-focused company incorporating:
Clinical Trials Application underway
Conventional detox clinics in operation in 2021
Phase 2 Clinical Trials begin in 2022
Multi-site, multi-country Phase 3 Clinical Trials begin in Q1 2022 (current target: Canada, Australia, New Zealand)
Our balance between medical expertise, corporate know-how, and capital markets understanding means we are well set for success.
Financials will be available once they are filed and we are a fully reporting publicly traded company.
We are currently completing a Subscription Receipt Qualifying Transaction, with the aim of becoming a public company in Q3 2021.
Being publicly owned allows everyone to be a part of the solution and enables us to obtain required funding for clinical trials in Canada and overseas
Board of Directors
Chief Ian Campbell, MBA
Dr. Alberta Sola, Ph.D
CoFounder & Director
Robert Turner, MBA
Contact the Team
Get Your Investor Report
P SQUARED RENEWABLES INC. AND UNIVERSAL IBOGAINE INC. ANNOUNCE TSX.V CONDITIONAL APPROVAL OF QUALIFYING TRANSACTION
Calgary, Alberta – P Squared Renewables Inc. (TSXV: PSQ.P) (“PSQ” or the “Company“) a capital
P Squared Renewables Inc. Provides Update on Con-Current Financing and QT and Announces Changes to Board Of Directors
Calgary, Alberta – P Squared Renewables Inc. (TSXV: PSQ.P) (“PSQ” or the “Company”) a capital
PSquared Renewables Inc and Universal Ibogaine Inc. engage Boustead Securities, LLC to Participate in Go-Public Financing
Calgary, Alberta – P Squared Renewables Inc. (TSXV: PSQ.P) (“PSQ”) a capital pool company, and